IL17A and inflammatory bowel disease: Put together, perhaps this altered cytokine production in IBD reflects the fact that during chronic inflammation, the production of IL-17 by MAIT cells together with other IL-17 producing immune cells provides attenuation of the inflammatory activity operating, therefore, as part of the body’s immune resolution mechanism to control the disease.